Search Within

Navid Sadri

Formats
  1. Meeting Abstract (5)
  2. Journal Article (1)
Groups
  1. Department of Pathology and Laboratory Medicine (3)
  2. GSK Faculty (2)
  3. Human Oncology and Pathogenesis Program (2)
  4. Tow Center for Developmental Oncology (TCDO) (2)
People
  1. Abhinita Mohanty (3)
  2. Ahmet Zehir (3)
  3. George Jour (3)
  4. Ryma Benayed (3)
  5. Shaozhou Tian (3)
  6. Sumit Middha (3)

More People

Years
  1. 2016 (1)
  2. 2015 (5)
Publications
  1. Journal of Molecular Diagnostics (3)
  2. Human Pathology (1)
  3. Laboratory Investigation (1)
  4. Modern Pathology (1)
Publishers
  1. Elsevier Science, Inc. (3)
  2. Elsevier Inc. (1)
  3. Nature Publishing Group (1)
  4. Nature Research (1)

Results (6)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Acinic cell carcinoma of breast: Morphologic and immunohistochemical review of a rare breast cancer subtype
    Journal Article

    Conlon, N.; Sadri, N.; Corben, A. D.; Tan, L. K.
    Human Pathology (2016)

    Fulltext@MSK | Save
  • Comprehensive prospective genomic profiling of tumor samples in the clinical laboratory: MSK-IMPACT experience in 4800 patients
    Meeting Abstract

    Zehir, A.; Benayed, R.; Cheng, D. T.; Chandramohan, R.; Sadowska, J.; Jour, G.; Mohanty, A.; Casanova, J.; Sadri, N.; Syed, A.; more...
    Journal of Molecular Diagnostics (2015)

    Fulltext@MSK | Save
  • Benefits and challenges of next generation sequencing in routine assessment of myeloid neoplasms: MSKCC two-year experience
    Meeting Abstract

    Middha, S.; Zaidinski, M.; Son, J.; Mohanty, A.; Zehir, A.; Cheng, D.; Nafa, K.; Benayed, R.; Jour, G.; Tian, S.; more...
    Journal of Molecular Diagnostics (2015)

    Fulltext@MSK | Save
  • Clinical monitoring of patients with myeloid malignancies using targeted next-generation sequencing
    Meeting Abstract

    Mohanty, A.; Zaidinski, M.; Son, J.; Zehir, A.; Middha, S.; Cheng, D. T.; Jour, G.; Tian, S. K.; DeLair, D.; Sadri, N.; more...
    Journal of Molecular Diagnostics (2015)

    Fulltext@MSK | Save
  • The Wnt receptor ROR2 is a novel prognostic marker and potential therapeutic target in dedifferentiated liposarcoma
    Meeting Abstract

    Sadri, N.; Simon, M. C.
    Laboratory Investigation (2015)

    Fulltext@MSK | Save
  • The Wnt receptor ROR2 is a novel prognostic marker and potential therapeutic target in dedifferentiated liposarcoma
    Meeting Abstract

    Sadri, N.; Simon, M. C.
    Modern Pathology (2015)

    Fulltext@MSK | Save